Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,118 | -35,037 | -120,587 | -84,680 | -54,029 |
| Depreciation Amortization | 197 | 135 | 1,878 | 1,478 | 1,048 |
| Accounts receivable | N/A | N/A | 80 | N/A | N/A |
| Accounts payable and accrued liabilities | -958 | -1,269 | 2,607 | 2,749 | 469 |
| Other Working Capital | 12,627 | 19,538 | 6,443 | 6,045 | 519 |
| Other Operating Activity | 9,551 | 5,489 | 14,237 | 7,462 | 6,511 |
| Operating Cash Flow | $-47,701 | $-11,144 | $-95,342 | $-66,946 | $-45,482 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,189 | -1,053 | -2,525 | -2,037 | -1,507 |
| Purchase Of Investment | -212,197 | -199,265 | -36,028 | -36,028 | -36,028 |
| Sale Of Investment | 18,000 | N/A | 157,445 | 60,655 | 45,655 |
| Other Investing Activity | -100 | 0 | -100 | -100 | -100 |
| Investing Cash Flow | $-196,486 | $-200,318 | $118,792 | $22,490 | $8,020 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -932 | -932 | -3,636 | -2,727 | -1,842 |
| Common Stock Issued | 3,834 | 617 | 200,797 | 40,876 | 30,661 |
| Other Financing Activity | -2,179 | -1,907 | -1,217 | -871 | -664 |
| Financing Cash Flow | $723 | $-2,222 | $195,944 | $37,278 | $28,155 |
| Beginning Cash Position | 283,476 | 283,476 | 64,082 | 64,082 | 64,082 |
| End Cash Position | 40,012 | 69,792 | 283,476 | 56,904 | 54,775 |
| Net Cash Flow | $-243,464 | $-213,684 | $219,394 | $-7,178 | $-9,307 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,701 | -11,144 | -95,342 | -66,946 | -45,482 |
| Capital Expenditure | -2,335 | -1,068 | -2,525 | -2,037 | -1,507 |
| Free Cash Flow | -50,036 | -12,212 | -97,867 | -68,983 | -46,989 |